Basaglar Follow-On Insulin Booms For Eli Lilly

 
• By Aidan Fry
  
DollarsGraph
Rapid volume uptake in the US is pushing Eli Lilly's Basaglar follow-on insulin towards blockbuster status • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business